HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Figure All Versions of this Article: 292/4/G1114    most recent 00528.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (19) Citing Articles via Google Scholar Google Scholar Articles by Shah, Y. M. Articles by Gonzalez, F. J. Search for Related Content PubMed PubMed Citation Articles by Shah, Y. M. Articles by Gonzalez, F. J.

MUCOSAL BIOLOGY

Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-B target gene expression

Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Submitted 11 November 2006 ; accepted in final form 14 December 2006

Pregnane X receptor (PXR) expression was shown to be protective in inflammatory bowel disease (IBD). However, the mechanism by which PXR provides protection remains unclear. Wild-type and Pxr-null mice were treated with the PXR agonist pregnenolone-16-carbonitrile or vehicle and administered 2.5% dextran sulfate sodium (DSS) in drinking water to induce IBD. Typical clinical symptoms were evaluated on a daily basis. In vivo intestinal permeability assays and proinflammatory cytokine analysis were performed. PXR agonist-treated mice were protected from DSS-induced colitis compared with vehicle-treated mice, as defined by body weight loss, diarrhea, rectal bleeding, colon length, and histology. Pregnenolone-16-carbonitrile did not decrease the severity of IBD in Pxr-null mice. PXR agonist treatment did not increase epithelial barrier function but did decrease mRNA expression of several NF-B target genes in a PXR-dependent manner. The present study clearly demonstrates a protective role for PXR agonist in DSS-induced IBD. The data suggest that PXR-mediated repression of NF-B target genes in the colon is a critical mechanism by which PXR activation decreases the susceptibility of mice to DSS-induced IBD.

pregnane X receptor; peroxisome proliferator-activated receptor-; chemokine (C-C motif) receptor 2; Crohn's disease; dextran sulfate sodium; monocyte chemoattractant protein-1

This article has been cited by other articles:

				K. Lichti-Kaiser, D. Brobst, C. Xu, and J. L. Staudinger A Systematic Analysis of Predicted Phosphorylation Sites within the Human Pregnane X Receptor Protein J. Pharmacol. Exp. Ther., October 1, 2009; 331(1): 65 - 76. [Abstract] [Full Text] [PDF]

				M.-J. Liu, Y. Takahashi, T. Wada, J. He, J. Gao, Y. Tian, S. Li, and W. Xie The Aldo-Keto Reductase Akr1b7 Gene Is a Common Transcriptional Target of Xenobiotic Receptors Pregnane X Receptor and Constitutive Androstane Receptor Mol. Pharmacol., September 1, 2009; 76(3): 604 - 611. [Abstract] [Full Text] [PDF]

				S. R. Pondugula, C. Brimer-Cline, J. Wu, E. G. Schuetz, R. K. Tyagi, and T. Chen A Phosphomimetic Mutation at Threonine-57 Abolishes Transactivation Activity and Alters Nuclear Localization Pattern of Human Pregnane X Receptor Drug Metab. Dispos., April 1, 2009; 37(4): 719 - 730. [Abstract] [Full Text] [PDF]

				D. G. Teotico, J. J. Bischof, L. Peng, S. A. Kliewer, and M. R. Redinbo Structural Basis of Human Pregnane X Receptor Activation by the Hops Constituent Colupulone Mol. Pharmacol., December 1, 2008; 74(6): 1512 - 1520. [Abstract] [Full Text] [PDF]